Summary
In 14 insulin dependent diabetics past their initial remission period B-cell function was evaluated using a test meal before and after 1 week of strict blood glucose control, and again 3 weeks later when the patients were outpatients on conventional therapy. Eight patients with fasting C-peptide above 0.07 nmol/l improved their B-cell function significantly (p<0.05) during the period of strict blood glucose control. However, the improvement was of short duration and was absent 3 weeks later in most patients. Six patients with fasting C-peptide below or equal to 0.07 nmol/l had no significant improvement in B-cell function during the period of strict control. The study shows that B-cell function and degree of blood glucose control are related in patients with fasting C-peptide above 0.07 nmol/l, and that B-cell function can change within days.
Article PDF
Similar content being viewed by others
References
Ludvigsson J, Heding LG (1978) Beta-cell function in children with diabetes. Diabetes 27 [Suppl 1]: 230–234
Krarup T, Madsbad S, Regeur L, Binder C, Faber O (1979) Beta-cell function during initial treatment in insulin dependent diabetics. Acta Endocrinol [Suppl] (Kbh) 277: 44
Faber OK, Binder C (1977) Plasma C-peptide during the first year of insulin-dependent diabetes mellitus. Int Congr Series No 413. Excerpta Medica, Amsterdam, p 149–154
Block MB, Rosenfield RL, Mako ME, Steiner DF, Rubenstein AH (1973) Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity. N Engl J Med 288: 1144–1148
Hernandez A, Zorilla E, Gershberg H (1968) Serum-insulin in remission of juvenile diabetes. Lancet II: 223
Weber B (1972) Glucose stimulated insulin secretion during remission of juvenile diabetes. Diabetologia 189–195
Ludvigsson J, Heding LG, Larson Y (1977) C-peptide in juvenile diabetics beyond the post-initial remission period. Acta Paediatr Scand 66: 177–184
Grajwer LA, Pildes RS, Horwitz DL, Rubenstein AH (1977) Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity. J Pediatr 90: 42–48
Gonen B, Goldman J, Baldwin D, Goldberg RB, Ryan WG, Blix PM, Schanzlin D, Frits KH, Rubenstein AH (1979) Metabolic control in diabetic patients. Effect of insulin-secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodies. Diabetes 28: 749–753
Madsbad S, Alberti KGMM, Binder C, Faber OK, Hudson A, Krarup T, Regeur L (1979) Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. Br Med J II: 1257–1259
Mirouze J, Selam JL, Phan TC, Mendoza E, Orsetti A (1978) Sustained insulin-induced remissions of juvenile diabetes by means of an external pancreas. Diabetologia 14: 223–227
Natvig H (1956) Nye Høyde —Vekttabeller for norske kvinner og menn. Landsforeningen for kosthold og helse, Oslo
Faber OK, Hagen C, Binder C, Markussen J, Naithani VK, Blix PM, Kuzuya H, Horwitz DL, Rubenstein AH (1978) Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 62: 197–203
Trinder P (1969) Determination of blood glucose using 4-aminophenazone as oxygen acceptor. J Clin Pathol 22: 246
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Faber OK, Markussen J, Naithani VK, Binder C (1976) Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin. Hoppe-Seylers Z Physiol Chem 357: 751–757
Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, Blix P, Horwitz DL, Rubenstein AH (1978) Characterization of seven C-peptide antisera. Diabetes 27 [Suppl 1]: 170–177
Schlichtkrull J, Munck O, Jersild M (1965) The M-value, an index of blood-sugar control in diabetics. Acta Med Scand 177: 95–102
Hendriksen C, Faber OK, Drejer J, Binder C (1977) Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon. Diabetologia 13: 615–619
Faber OK, Wahren J, Ferrannini E, Binder C, DeFronzo RA (1978) Direct effect of insulin on the beta-cell function. Diabetologia 15: 230
Turner RC, McCarthy ST, Holman RR, Harris E (1976) Betacell function improved by supplementing basal insulin secretion in mild diabetes. Br Med J I: 1252–1254
Pickup JC, Keen H, Parsons JA, Alberti KGMM, Rowe AS (1979) Continous subcutaneous insulin infusion: improved blood glucose and intermediary-metabolite control in diabetics. Lancet I: 1255–1258
Tanborlane WV, Sherwin RS, Genel M, Felig P (1979) Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 11: 573–578
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Madsbad, S., Krarup, T., Regeur, L. et al. Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics. Diabetologia 20, 530–534 (1981). https://doi.org/10.1007/BF00252760
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00252760